The relationship and clinical significance of lactylation modification in digestive system tumors
Open Access
- 15 July 2024
- journal article
- review article
- Published by Springer Nature in Cancer Cell International
- Vol. 24 (1) , 1-20
Abstract
Lactylation, an emerging post-translational modification, plays a pivotal role in the initiation and progression of digestive system tumors. This study presents a comprehensive review of lactylation in digestive system tumors, underscoring its critical involvement in tumor development and progression. By focusing on metabolic reprogramming, modulation of the tumor microenvironment, and the molecular mechanisms regulating tumor progression, the potential of targeting lactylation as a therapeutic strategy is highlighted. The research reveals that lactylation participates in gene expression regulation and cell signaling by affecting the post-translational states of histones and non-histone proteins, thereby influencing metabolic pathways and immune evasion mechanisms in tumor cells. Furthermore, this study assesses the feasibility of lactylation as a therapeutic target, providing insights for clinical treatment of gastrointestinal cancers. Future research should concentrate on elucidating the mechanisms of lactylation, developing efficient lactylation inhibitors, and validating their therapeutic efficacy in clinical trials, which could transform current cancer treatment and immunotherapy approaches. In summary, this review emphasizes the crucial role of lactylation in tumorigenesis and progression through a detailed analysis of its molecular mechanisms and clinical significance.Keywords
Funding Information
- Guangxi Youth Science Fund Project (2024GXNSFBA010103)
- National Natural Science Foundation of China (82360495)
- the Guangxi Science and Technology Major Project (Guike AA22096018)
- Guangxi Science and Technology Base and Talent Project (GuiKe AD20297069)
This publication has 153 references indexed in Scilit:
- Integrative analysis of lactylation-related genes and establishment of a novel prognostic signature for hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2023
- Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targetsMedcomm, 2023
- Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinomaProteomics, 2023
- Patient‐derived organoids for personalized gallbladder cancer modelling and drug screeningClinical and Translational Medicine, 2022
- Prospective study of oral microbiome and gastric cancer risk among Asian, African American and European American populationsInternational Journal of Cancer, 2021
- The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinomaCochrane Database of Systematic Reviews, 2019
- Prognostic role of glycolysis for cancer outcome: evidence from 86 studiesJournal of Cancer Research and Clinical Oncology, 2019
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National LevelJAMA Oncology, 2017
- 1H nuclear magnetic resonance (NMR)-based serum metabolomics of human gallbladder inflammationInflammation Research, 2016
- Effect of tumor cells and tumor microenvironment on NK‐cell functionEuropean Journal of Immunology, 2014